Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosaopen access
- Authors
- Cho, Jung Keun; Curtis-Long, Marcus J.; Lee, Kon Ho; Kim, Dae Wook; Ryu, Hyung Won; Yuk, Heung Joo; Park, Ki Hun
- Issue Date
- 1-Jun-2013
- Publisher
- PERGAMON-ELSEVIER SCIENCE LTD
- Keywords
- SARS-CoV PLpro; Paulownia tomentosa; Geranylated flavonoids; PLpro inhibitor
- Citation
- BIOORGANIC & MEDICINAL CHEMISTRY, v.21, no.11, pp 3051 - 3057
- Pages
- 7
- Indexed
- SCI
SCIE
SCOPUS
- Journal Title
- BIOORGANIC & MEDICINAL CHEMISTRY
- Volume
- 21
- Number
- 11
- Start Page
- 3051
- End Page
- 3057
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/20625
- DOI
- 10.1016/j.bmc.2013.03.027
- ISSN
- 0968-0896
1464-3391
- Abstract
- SARS-CoV papain-like protease (PLpro) is an important antiviral target due to its key roles in SARS virus replication. The MeOH extracts of the fruits of the Paulownia tree yielded many small molecules capable of targeting PLpro. Five of these compounds were new geranylated flavonoids, tomentin A, tomentin B, tomentin C, tomentin D, tomentin E (1-5). Structure analysis of new compounds (1-5) by NMR showed that they all contain a 3,4-dihydro-2H-pyran moiety. This chemotype is very rare and is derived from cyclization of a geranyl group with a phenol functionality. Most compounds (1-12) inhibited PLpro in a dose dependent manner with IC50's raging between 5.0 and 14.4 mu M. All new compounds having the dihydro-2H-pyran group showed better inhibition than their parent compounds (1 vs 11, 2 vs 9, 4 vs 12, 5 vs 6). In kinetic studies, 1-12 emerged to be reversible, mixed inhibitors. (C) 2013 Elsevier Ltd. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.